Molecular Definition of Breast Tumor Heterogeneity

Cancer Cell

Volumn 11, Issue 3, 2007, Pages 259-273

  Shipitsin, Michail ^a,b   Campbell, Lauren L ^a,b   Argani, Pedram ^c   Weremowicz, Stanislawa ^b,g   Bloushtain Qimron, Noga ^a   Yao, Jun ^a,b   Nikolskaya, Tatiana ^d,e   Serebryiskaya, Tatiana ^d,e   Beroukhim, Rameen ^a,b   Hu, Min ^a,b   Halushka, Marc K ^c   Sukumar, Saraswati ^c   Parker, Leroy M ^a,b   Anderson, Karen S ^a,b   Harris, Lyndsay N ^a,b   Garber, Judy E ^a,b   Richardson, Andrea L ^b,g   Schnitt, Stuart J ^b,h   Nikolsky, Yuri ^d   Gelman, Rebecca S ^a,f   Polyak, Kornelia ^a,b   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GeneGo bioinformatics software Inc   (United States)

^e VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CELLCYCLE

Indexed keywords

CD24 ANTIGEN; CELL MARKER; HERMES ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

ARTICLE; BREAST; BREAST CANCER; BREAST TUMOR; CANCER CELL; CANCER SURVIVAL; CELL CLONING; CELL HETEROGENEITY; CELL POPULATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PURIFICATION; STEM CELL;

EID: 33847419142     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.01.013     Document Type: Article

References (57)

1. Abraham B.K., Fritz P., McClellan M., Hauptvogel P., Athelogou M., and Brauch H. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin. Cancer Res. 11 (2005) 1154-1159
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
4. Arteaga C.L. Inhibition of TGFbeta signaling in cancer therapy. Curr. Opin. Genet. Dev. 16 (2006) 30-37
5. Asselin-Labat M.L., Shackleton M., Stingl J., Vaillant F., Forrest N.C., Eaves C.J., Visvader J.E., and Lindeman G.J. Steroid hormone receptor status of mouse mammary stem cells. J. Natl. Cancer Inst. 98 (2006) 1011-1014
6. Bates R.C., and Mercurio A.M. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4 (2005) 365-370
7. Baumann P., Cremers N., Kroese F., Orend G., Chiquet-Ehrismann R., Uede T., Yagita H., and Sleeman J.P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 65 (2005) 10783-10793
8. Bircan S., Kapucuoglu N., Baspinar S., Inan G., and Candir O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study. Pathol. Res. Pract. 202 (2006) 569-576
9. Blanpain C., Lowry W.E., Geoghegan A., Polak L., and Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118 (2004) 635-648
10. Bocker W., Moll R., Poremba C., Holland R., Van Diest P.J., Dervan P., Burger H., Wai D., Ina Diallo R., Brandt B., et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept. Lab. Invest. 82 (2002) 737-746
11. Chang H.Y., Nuyten D.S., Sneddon J.B., Hastie T., Tibshirani R., Sorlie T., Dai H., He Y.D., van't Veer L.J., Bartelink H., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl. Acad. Sci. USA 102 (2005) 3738-3743
12. Clarke M.F., and Fuller M. Stem cells and cancer: Two faces of eve. Cell 124 (2006) 1111-1115
13. Clarke R.B., Spence K., Anderson E., Howell A., Okano H., and Potten C.S. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol. 277 (2005) 443-456
14. Clayton H., Titley I., and Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp. Cell Res. 297 (2004) 444-460
15. Dean M., Fojo T., and Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5 (2005) 275-284
16. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (2003) 1253-1270
17. Eckfeldt C.E., Mendenhall E.M., and Verfaillie C.M. The molecular repertoire of the 'almighty' stem cell. Nat. Rev. Mol. Cell Biol. 6 (2005) 726-737
18. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95 (1998) 14863-14868
19. Ekins S., Andreyev S., Ryabov A., Kirillov E., Rakhmatulin E.A., Sorokina S., Bugrim A., and Nikolskaya T. A combined approach to drug metabolism and toxicity assessment. Drug Metab. Dispos. 34 (2006) 495-503
20. Glinsky G.V., Berezovska O., and Glinskii A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115 (2005) 1503-1521
21. Hu M., Yao J., Cai L., Bachman K.E., van den Brule F., Velculescu V., and Polyak K. Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 37 (2005) 899-905
22. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., and Lemischka I.R. A stem cell molecular signature. Science 298 (2002) 601-604
23. James D., Levine A.J., Besser D., and Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132 (2005) 1273-1282
24. Jarvinen A.K., Autio R., Haapa-Paananen S., Wolf M., Saarela M., Grenman R., Leivo I., Kallioniemi O., Makitie A.A., and Monni O. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25 (2006) 6997-7008
25. Kristiansen G., Winzer K.J., Mayordomo E., Bellach J., Schluns K., Denkert C., Dahl E., Pilarsky C., Altevogt P., Guski H., and Dietel M. CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 9 (2003) 4906-4913
26. LaFramboise T., Weir B.A., Zhao X., Beroukhim R., Li C., Harrington D., Sellers W.R., and Meyerson M. Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput. Biol. 1 (2005) e65 10.1371/journal.pcbi.0010065
27. Lee T.L., Alba D., Baxendale V., Rennert O.M., and Chan W.Y. Application of transcriptional and biological network analyses in mouse germ-cell transcriptomes. Genomics 88 (2006) 18-33
28. Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., and Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66 (2006) 6063-6071
29. Lynch M.D., Cariati M., and Purushotham A.D. Breast cancer, stem cells and prospects for therapy. Breast Cancer Res. 8 (2006) 211
30. Moses H.L., and Serra R. Regulation of differentiation by TGF-beta. Curr. Opin. Genet. Dev. 6 (1996) 581-586
31. Muraoka-Cook R.S., Dumont N., and Arteaga C.L. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin. Cancer Res. 11 (2005) 937s-943s
32. Ney P.A., Andrews N.C., Jane S.M., Safer B., Purucker M.E., Weremowicz S., Morton C.C., Goff S.C., Orkin S.H., and Nienhuis A.W. Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol. Cell. Biol. 13 (1993) 5604-5612
33. Nikolsky Y., Ekins S., Nikolskaya T., and Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158 (2005) 20-29
34. Nikolsky Y., Nikolskaya T., and Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov. Today 10 (2005) 653-662
35. Osada H., Tatematsu Y., Sugito N., Horio Y., and Takahashi T. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Mol. Carcinog. 44 (2005) 233-241
36. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., and Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 65 (2005) 6207-6219
37. Polyak K. Pregnancy and breast cancer: The other side of the coin. Cancer Cell 9 (2006) 151-153
38. Polyak K., and Hahn W.C. Roots and stems: Stem cells in cancer. Nat. Med. 12 (2006) 296-300
39. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., and Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
40. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., and Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65 (2005) 5506-5511
41. Porter D., Lahti-Domenici J., Keshaviah A., Bae Y.K., Argani P., Marks J., Richardson A., Cooper A., Strausberg R., Riggins G.J., et al. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 1 (2003) 362-375
42. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., and Melton D.A. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298 (2002) 597-600
43. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 8621-8623
44. Russo J., Moral R., Balogh G.A., Mailo D., and Russo I.H. The protective role of pregnancy in breast cancer. Breast Cancer Res. 7 (2005) 131-142
45. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat. Rev. Cancer 6 (2006) 281-291
46. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3 (2003) 807-821
47. Soreghan B.A., Lu B.W., Thomas S.N., Duff K., Rakhmatulin E.A., Nikolskaya T., Chen T., and Yang A.J. Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alzheimer's disease. J. Alzheimers Dis. 8 (2005) 227-241
48. Sotiriou C., Wirapati P., Loi S., Harris A., Fox S., Smeds J., Nordgren H., Farmer P., Praz V., Haibe-Kains B., et al. Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J. Natl. Cancer Inst. 98 (2006) 262-272
49. Stingl J., Eaves C.J., Kuusk U., and Emerman J.T. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 63 (1998) 201-213
50. Stingl J., Raouf A., Emerman J.T., and Eaves C.J. Epithelial progenitors in the normal human mammary gland. J. Mammary Gland Biol. Neoplasia 10 (2005) 49-59
51. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
52. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
53. Weissman I.L. Normal and neoplastic stem cells. Novartis Found. Symp. 265 (2005) 35-50 discussion 50-34, 92-37
54. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: An old idea-A paradigm shift. Cancer Res. 66 (2006) 1883-1890
55. Zhang H.T., Chen X.F., Wang M.H., Wang J.C., Qi Q.Y., Zhang R.M., Xu W.Q., Fei Q.Y., Wang F., Cheng Q.Q., et al. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin. Cancer Res. 10 (2004) 2359-2367
56. Zhao Y., Bjorbaek C., Weremowicz S., Morton C.C., and Moller D.E. RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: Growth factor-stimulated kinase function and nuclear translocation. Mol. Cell. Biol. 15 (1995) 4353-4363
57. Zhao H., Shiina H., Greene K.L., Li L.C., Tanaka Y., Kishi H., Igawa M., Kane C.J., Carroll P., and Dahiya R. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer 104 (2005) 44-52